Legend Biotech to Host Investor Conference Call on Third Quarter 2025 Results

Rhea-AI Summary

Legend Biotech (NASDAQ: LEGN) will host a live investor conference call and webcast at 8:00 AM ET on Wednesday, November 12, 2025 to review third quarter 2025 results. Senior leaders will provide an overview of the company’s performance for the quarter.

Investors can join the live audio webcast via the company weblink. A replay of the webcast and the earnings news release will be posted in the Investor Relations site under Events and Presentations approximately two hours after the call concludes.

SOMERSET, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Wednesday, November 12, 2025, to review third quarter 2025 results.

During the webcast and conference call, senior leaders will provide an overview of Legend Biotech’s performance for the quarter.

Investors and other interested parties may join the live audio webcast of the call via this weblink.

A replay of the webcast and earnings news release will be available through the Investor Relations section of Legend Biotech’s website under the Events and Presentations section approximately two hours after the call concludes.

ABOUT LEGEND BIOTECH

With over 2,800 employees, Legend Biotech is the largest standalone cell therapy company and a pioneer in treatments that change cancer care forever. The company is at the forefront of the CAR-T cell therapy revolution with CARVYKTI^®, a one-time treatment for relapsed or refractory multiple myeloma, which it develops and markets with collaborator Johnson & Johnson. Centered in the US, Legend is building an end-to-end cell therapy company by expanding its leadership to maximize CARVYKTI’s patient access and therapeutic potential. From this platform, the company plans to drive future innovation across its pipeline of cutting-edge cell therapy modalities.

Learn more at www.legendbiotech.com, and follow us on LinkedIn.

INVESTOR CONTACT:

Jessie Yeung
Tel: (732) 956-8271
jessie.yeung@legendbiotech.com

PRESS CONTACT:
Alexandra Ventura
Tel: (732) 850-5598
media@legendbiotech.com

FAQ

When will Legend Biotech (LEGN) discuss Q3 2025 results?

Legend Biotech will review Q3 2025 results on Wednesday, November 12, 2025 at 8:00 AM ET.

How can I join the Legend Biotech (LEGN) Q3 2025 earnings call webcast?

Join the live audio webcast via the company’s investor relations weblink provided for the November 12, 2025 call.

When will the replay and earnings release for LEGN Q3 2025 be available?

A replay and the earnings news release will be available in Investor Relations under Events and Presentations about two hours after the call ends.

Who will present on Legend Biotech’s Q3 2025 conference call?

Senior leaders of Legend Biotech will provide an overview of the company’s performance during the call.

Where on Legend Biotech’s site can investors find the Q3 2025 webcast recording?

The recording and related materials will be posted in the Investor Relations > Events and Presentations section of the Legend Biotech website.

Is registration required to access the LEGN Q3 2025 webcast on November 12, 2025?

The notice directs investors to join via the company weblink; check the investor relations page for any registration details ahead of the 8:00 AM ET call.